AFT Pharmaceuticals Ltd
NZX:AFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
NZ |
|
G
|
Green Thumb Industries Inc
CNSX:GTII
|
US |
Wall St Price Targets
AFT Price Targets Summary
AFT Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for AFT is 4.74 NZD with a low forecast of 4.29 NZD and a high forecast of 5.3 NZD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AFT's stock price target?
Price Target
4.74
NZD
According to Wall Street analysts, the average 1-year price target for AFT is 4.74 NZD with a low forecast of 4.29 NZD and a high forecast of 5.3 NZD.
What is the Revenue forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
18%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 18%.
What is the Operating Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
29%
Over the last 12 years, the compound annual growth rate for Operating Income has been 26%. The projected CAGR for the next 3 years is 29%.
What is the Pre-Tax Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
32%
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 39%. The projected CAGR for the next 3 years is 32%.
What is the Net Income forecast for AFT Pharmaceuticals Ltd?
Projected CAGR
30%
Over the last 12 years, the compound annual growth rate for Net Income has been 43%. The projected CAGR for the next 3 years is 30%.
